March 6, 2017
Remembering Dr. Thomas E. Starzl
Ricardo Ordoñez | Sr. Director of Marketing & Customer Experience
Dr. Starzl directed the University of Pittsburgh Transplantation Institute which was later renamed the Thomas E. Starzl Transplantation Institute in 1996. His many innovations at the institute greatly impacted the field of transplantation. Under his leadership, the institute researched the feasibility of xenotransplantation for addressing the chronic shortage of human organs. In 1992 and 1993, Dr. Starzl's team made medical history when surgeons performed two baboon-to-human liver transplants.
For more than 50 years, Dr. Starzl was a great friend and scientific collaborator of HLA pioneer and founder of One Lambda, Inc., Dr. Paul Terasaki. In 1964, Dr. Starzl played a pivotal role in the development and evaluation of Dr. Terasaki's microcytotoxicity assay.
One Lambda, A Thermo Fisher Scientific Brand extends our deepest condolences to the Starzl Family and to many of our friends in the HLA and Transplantation community who had the distinct honor of working with this incredible scientist and pioneer.